Trevena, Inc. (TRVN) To Host Conference Call To Discuss Second Quarter 2014 Results On August 12
8/5/2014 9:54:03 AM
Trevena, Inc. (NASDAQ: TRVN), a clinical stage pharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that it will host a conference call on Tuesday, August 12, 2014 at 8:30 a.m. EDT to discuss its financial and operational results for the second quarter ended June 30, 2014. The company will issue a press release reporting its results at approximately 7:00 a.m. EDT on August 12.
Help employers find you! Check out all the jobs and post your resume.
comments powered by